Jyothy Labs announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a 3.3% increase in revenue to ₹760 Crores for the September quarter. However, the gross margin saw a significant decline to 34.8% from 48.1% in the same period last year, attributed to abnormal inflation in raw materials and packaging costs. Operating EBITDA also decreased substantially.
Jyothy Labs Announces Q2 FY27 Financial Highlights
Jyothy Labs Limited has released its financial performance for the second quarter and the first half of the financial year 2027, ending on September 30, 2026. The company reported a notable 3.3% rise in revenue for the quarter, reaching ₹760 Crores, compared to ₹736 Crores in the previous year. Excluding the impact of Pril & Fa, the value growth for Q2 FY27 was 12.4% with a volume growth of 8.1%.
Profitability and Margins Under Pressure
Despite revenue growth, the company’s profitability faced challenges. The Gross Margin for the September quarter stood at 34.8%, a substantial decrease from 48.1% in the corresponding period of the previous year. This decline is primarily due to significant inflation in raw material and packaging costs. Advertising and Promotion (A&P) spend was recorded at ₹56.5 Crores (7.4% of Revenue from Operation).
EBITDA and PAT Decline
Operating EBITDA experienced a significant contraction, falling to ₹19.2 Crores (2.5% of Revenue) from ₹118.3 Crores (16.1% of Revenue) in the prior year’s quarter. Consequently, Profit After Tax (PAT) was ₹10.6 Crores, a sharp decrease from ₹87.8 Crores in the same quarter last year. The PAT margin stood at 1.4%.
Half-Yearly Performance Snapshot
For the half-year ended September 30, 2026, revenue grew by 3.1% to ₹1,533 Crores from ₹1,487 Crores. The gross margin for H1 FY27 was 36.7%, down from 48.0% in the previous year. Operating EBITDA for the half-year stood at ₹83.9 Crores (5.5% of Revenue), a significant drop from ₹242.4 Crores (16.3% of Revenue). PAT for the half-year was ₹58.2 Crores, down from ₹184.6 Crores.
Key Financial Parameters
The financial highlights also indicate a cash balance of ₹846 Crores as of September 30, 2026. The A&P to Sales Ratio for the September quarter was 7.4%, and for the half-year it was 7.0%.
Category Performance
In terms of category performance for Q2 FY27, Fabric Care showed a growth of 10.4%. Home Care (without Pril) grew by 15.3%, while Personal Care saw a growth of 11.2%. Home Care (with Pril) experienced a decline of 7.1%.
Way Forward Strategy
Looking ahead, Jyothy Labs plans to drive profitable volume-led growth through innovation, premiumisation, and deeper market penetration, supported by selective price increases. The company aims to scale recent launches like Maxo Incense Sticks and Exo dishwash liquid, and further strengthen its innovation pipeline. Managing input cost volatility through calibrated pricing and value engineering remains a key focus.
Source: BSE
